Japan Agency Says New Drugs Caused Fulminant Hepatitis Deaths
This article was originally published in PharmAsia News
Executive Summary
Japan's health ministry said drugs new on the market for treating blood cancer and rheumatism were responsible for the deaths of some hepatitis B patients